| scholarly article | Q13442814 |
| P2093 | author name string | P J Newman | |
| R H Aster | |||
| R S Derbes | |||
| P2860 | cites work | Structure of platelet glycoprotein IIIa. A common subunit for two different membrane receptors | Q24337304 |
| IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY" | Q33371182 | ||
| The biochemistry of platelet-specific alloantigens | Q33411410 | ||
| On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa | Q33412847 | ||
| Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP | Q33476492 | ||
| Clinical significance of platelet-specific antigens and antibodies | Q33477665 | ||
| Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction | Q34560935 | ||
| A Taq 1 polymorphism for the human platelet glycoprotein IIIa gene (GP3A). | Q36060791 | ||
| Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. | Q36435847 | ||
| Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". | Q36460328 | ||
| The platelet membrane glycoprotein IIb-IIIa complex. | Q39195582 | ||
| Studies on the nature of the human platelet alloantigen, PlA1: localization to a 17,000-dalton polypeptide | Q45280580 | ||
| Characterization of platelet-specific alloantigens by immunoblotting: localization of Zw and Bak antigens | Q69714994 | ||
| Simple non-invasive method to obtain DNA for gene analysis | Q69919298 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1778-1781 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing | |
| P478 | volume | 83 |
| Q35024990 | A multilocus genotyping assay for candidate markers of cardiovascular disease risk |
| Q33489020 | A platelet monoclonal antibody inhibition assay for detection of glycoprotein platelet alloantibodies |
| Q33331591 | A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a |
| Q40668561 | A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction |
| Q33448997 | Allele frequencies of the human platelet antigen-1 in the Egyptian population |
| Q71613627 | An additional HpaII polymorphism in exon 2 of the human platelet membrane glycoprotein IIIa gene |
| Q46892241 | An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees |
| Q54392340 | Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. |
| Q44199848 | Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin. |
| Q33491336 | Antenatal management of the thrombocytopenias. |
| Q33432924 | Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia |
| Q28201011 | Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4 |
| Q28183220 | Aspirin resistance: an evaluation of current evidence and measurement methods |
| Q24798317 | Assessment of Equine Autoimmune Thrombocytopenia (EAT) by flow cytometry |
| Q90069028 | Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis |
| Q54776438 | Association between the Pl(A) platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease. |
| Q38327059 | Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease |
| Q36249248 | Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study. |
| Q33381967 | Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia |
| Q33428137 | CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes |
| Q33503323 | Clinical aspects and typing of platelet alloantigens |
| Q37035275 | Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss |
| Q28191774 | Common variations in platelet glycoproteins: pharmacogenomic implications |
| Q33401637 | Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia |
| Q90514495 | Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes |
| Q34158852 | Demystified...adhesion molecule deficiencies |
| Q33393340 | Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads |
| Q43844871 | Detection of platelet-specific protein mRNAs in different megakaryoblasts using the reverse transcriptase polymerase chain reaction |
| Q33331875 | Development and validation of a genotyping kit for the eight principal human platelet alloantigen systems |
| Q36384030 | Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting |
| Q46934459 | Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists |
| Q92887664 | Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia |
| Q40690514 | Evaluation of an antibody-based genotype classification of the platelet fibrinogen receptor (GPIIb/IIIa). |
| Q36524428 | Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function. |
| Q33351609 | Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy |
| Q41512544 | Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study |
| Q26777281 | Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention |
| Q33373042 | Fetoneonatal alloimmune thrombocytopenia (FNAIT): our experience |
| Q33377139 | Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA |
| Q33377255 | Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pockets |
| Q92525071 | Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome |
| Q40645970 | Frequency distribution of antigens in the human platelet antigen-1 system in the western Indian population |
| Q42095291 | Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3. |
| Q34459073 | Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease |
| Q33404884 | Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia |
| Q43830350 | Genetic variation of the platelet- surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus |
| Q37347806 | Genomics: risk and outcomes in cardiac surgery |
| Q33384329 | Genotyping applied to platelet immunology: when? How? Limits |
| Q33488288 | HLA-DR3 subtypes associated with immunization against HLA-1a antigen in families with alloimmune neonatal thrombopenia |
| Q64105997 | HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women |
| Q33437901 | HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia |
| Q58554127 | High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (Pl) |
| Q46609352 | High-throughput simultaneous genotyping of human platelet antigen-1 to -16 by using suspension array |
| Q73341709 | Human platelet alloantigens |
| Q33411662 | Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model |
| Q33504452 | Human platelet antigen genotyping using a fluorescent SSCP technique with an automatic sequencer |
| Q33487895 | Human platelet antigen-1 (Zw) typing of fetuses by analysis of polymerase chain reaction-amplified genomic DNA from amniocytes |
| Q33492191 | Human platelet antigen-1 (Zw) typing using PCR-RFLP. |
| Q33503320 | Human platelet-specific alloantigens: update |
| Q37443528 | Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet Function |
| Q37174998 | Impact of genetic variation on perioperative bleeding |
| Q43230371 | Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease. |
| Q39527476 | Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis |
| Q33328304 | Inhibitory and activating human antiplatelet antibodies |
| Q37711750 | Integrin structure and function in hemostasis and thrombosis |
| Q37011736 | Integrin αIIbβ3: from discovery to efficacious therapeutic target |
| Q35170443 | Integrin-dependent pathologies |
| Q44309505 | Interaction between the platelet IIb/IIIa receptor gene and serotonin transporter gene is involved in the formation of the predisposition to myocardial infarction in young men. |
| Q34444907 | Invited review: Pharmacogenetics of estrogen replacement therapy |
| Q33487781 | Lack of binding of peptides carrying the human platelet antigen 1 (HPA-1) dimorphism to purified HLA-DRw52a molecules. |
| Q47897279 | Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction |
| Q38316992 | Localization of an O-glycosylation site in the alpha-subunit of the human platelet integrin GPIIb/IIIa involved in Baka (HPA-3a) alloantigen expression |
| Q71539263 | Management of fetal and neonatal alloimmune thrombocytopenia |
| Q73128810 | Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction |
| Q33404386 | Modeling and molecular dynamics of HPA-1a and -1b polymorphisms: effects on the structure of the β3 subunit of the αIIbβ3 integrin |
| Q33492452 | Molecular analysis of human platelet antigen system 1 antigen on single cells can be applied to preimplantation genetic diagnosis for prevention of alloimmune thrombocytopenia |
| Q33352633 | Molecular biology for platelet alloantigen typing |
| Q39944643 | Molecular cloning and expression of glycoprotein IIIa(T1565C). |
| Q36954760 | Molecular genetic aspects of human platelet antigen systems |
| Q33497352 | Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia |
| Q36459045 | Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: Enhanced outside-in signaling through the Pro33 variant of integrin beta3. |
| Q33414351 | Molecular typing of human platelet and neutrophil antigens (HPA and HNA). |
| Q41018895 | NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens |
| Q68039963 | Neonatal alloimmune thrombocytopenia |
| Q33405694 | Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management |
| Q35178930 | New Testing Approaches in Transfusion Medicine |
| Q33398132 | New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia |
| Q33421975 | Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing |
| Q47686829 | Novel diagnostic and therapeutic strategies with genetically engineered human antibodies |
| Q73073912 | PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis |
| Q48388471 | PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke |
| Q33617402 | PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort |
| Q74012797 | PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications |
| Q44473132 | Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. |
| Q33704606 | Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics |
| Q35111110 | Platelet Receptors and Their Role in Diseases |
| Q35930582 | Platelet adhesion to decorin but not collagen I correlates with the integrin α2 dimorphism E534K, the basis of the human platelet alloantigen (HPA)-5 system |
| Q48765978 | Platelet alloantigenic systems |
| Q30724883 | Platelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient |
| Q33502392 | Platelet and neutrophil alloantigen genotyping in clinical practice |
| Q33344146 | Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation |
| Q54244842 | Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke. |
| Q83785787 | Platelet glycoprotein IIIA PIA2 polymorphism is associated with ST elevation acute myocardial infarction in young Mexican population |
| Q35234099 | Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies |
| Q52228135 | Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators. |
| Q34434798 | Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies |
| Q34333809 | Platelet glycoproteins and their role in diseases |
| Q34565097 | Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective endocarditis |
| Q33497247 | Platelets and coagulation. An update |
| Q33440427 | Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia |
| Q33411360 | Polymorphisms in canine platelet glycoproteins identify potential platelet antigens |
| Q33348474 | Post-transfusion purpura (PTP) and disseminated intravascular coagulation (DIC). |
| Q41074935 | Posttransfusion purpura: two unusual cases and a literature review |
| Q33407728 | Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia |
| Q33340058 | Prenatal intracranial hemorrhage and neurologic complications in alloimmune thrombocytopenia |
| Q46614413 | Primary thrombophilia in Mexico IX: the glycoprotein IIIa PLA1/A2 polymorphism is not associated with the sticky platelet syndrome phenotype |
| Q33584613 | Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606. |
| Q92710090 | Prospects for risk stratification of anti-HPA-1a alloimmunized pregnant women |
| Q33347179 | Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis |
| Q33329519 | Rapid phenotyping of HPA-1a using either diabody-based hemagglutination or recombinant IgG1-based assays. |
| Q33368580 | Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism |
| Q33425658 | Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia. |
| Q32077931 | Receptor polymorphisms and diseases |
| Q33392862 | Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention |
| Q78176116 | Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease |
| Q35582425 | Role of platelet glycoprotein polymorphisms in cardiovascular diseases |
| Q37010375 | Significant correlation of angiotensin converting enzyme and glycoprotein IIIa genes polymorphisms with unexplained recurrent pregnancy loss in north of Iran |
| Q72024783 | Simultaneous DNA Typing of Human Platelet Antigens 2, 3 and 4 by an Allele‐Specific PCR Method |
| Q54218775 | Simultaneous genotyping of HPA-17w to -21w by PCR-SSP in Chinese Cantonese. |
| Q37396272 | Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes |
| Q43255962 | Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate |
| Q35213036 | Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics |
| Q90292261 | Structure of an extended β3 integrin |
| Q33392621 | Studies on the HLA Class-II Antigens of a Patient Presenting a Double Alloimmunization Following Posttransfusion Purpura. |
| Q33435753 | T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition |
| Q42754535 | Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis |
| Q33693990 | The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events |
| Q33381441 | The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend |
| Q40716748 | The Pl(A2) allele and cardiovascular disease: the pro(33) and con |
| Q38120047 | The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis |
| Q45163746 | The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health study |
| Q33395951 | The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia |
| Q44509448 | The combination of glycoprotein IIIa PlA polymorphism with polymorphism of serotonin transporter as an independent strong risk factor for the occurrence of coronary thrombosis |
| Q33398407 | The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes |
| Q46679754 | The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used |
| Q28193081 | The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events |
| Q34282183 | The genetics of normal platelet reactivity |
| Q40442876 | The glycoprotein IIIa gene polymorphism and the risk of myocardial infarction |
| Q33908423 | The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2) |
| Q37478529 | The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel |
| Q73404196 | The role of P‐selectin in the immune destruction of platelets |
| Q33845240 | The role of genetics in coronary artery bypass surgery patients under 30 years of age. |
| Q33443241 | Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation |
| Q50725105 | Variation of the platelet glycoprotein IIIa PI(A1/A2) allele frequencies in the three ethnic groups of Singapore. |
| Q36597746 | Vitronectin receptor: tissue specific expression or adaptation to culture? |
| Q42134004 | pH-, temperature- and ion-dependent oligomerization of Sulfolobus solfataricus recombinant amidase: a study with site-specific mutants |
Search more.